Thermo Fisher Shells Out $876M For Viral Vector Maker
By Sierra Jackson ( January 15, 2021, 9:29 PM EST) -- Lab equipment supplier Thermo Fisher said Friday that it coughed up €725 million ($876 million) in cash to purchase Henogen — a company that makes viral vectors to deliver genetic material into cells — from Cleary Gottlieb-guided life science technology and services provider Novasep....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.